SOLOSEC: payments to doctors
Payments that named SOLOSEC as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1M
- Providers
- 9,750
- Transactions
- 25,935
- Average per transaction
- $40
The per-transaction average — $40 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 9,750 providers the average total is $107, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Lupin Inc. | $946,235 | 90.5% |
| Evofem Biosciences, Inc. | $91,283 | 8.7% |
| Exeltis, USA Inc. | $8,136 | 0.8% |